Description of the Product
The Infant Bilirubin Phototherapy Unit YR02195 is an advanced apparatus designed specifically for the treatment of neonatal jaundice. This innovative unit offers exceptional therapeutic performance, utilizing a blue tube as its primary light source. This ensures effective treatment over an extended period, as the light source boasts an impressive lifespan of 1000 hours. The device emits a precise wavelength range of 400-550 nm, optimally tuned to address excess bilirubin levels safely.
Engineered for adaptability and precision, the unit allows flexible treatment distances from 10 to 500 pixels. The effective area of treatment is admirably large, measuring 1125 pixels by 600 pixels, ensuring comprehensive coverage. Additionally, the unit is cautiously designed to limit infrared radiation in the effective area to ≤10mW/cm² (with wavelengths ranging from 760 nm to 1400 nm) and ultraviolet radiation to ≤1.0×10-5 mW/cm² (within the 180 nm to 400 nm range).
Designed for ease of use and adjustment, the YR02195 model provides the capability to alter angles at 30°, 60°, and 90°, along with a height adjustment range from 1100 mm to 1500 mm, allowing caregivers to position the device accurately for optimal results. The ambient noise level during operation is maintained at a maximum of 55 dB(A), which is barely noticeable in settings with background noises lower than 40 dB(A). The unit requires less than 150 VA of input power, making it an energy-efficient solution for clinical settings. Notably, the basic operational performance of the unit delivers an irradiance level of ≥500 μW/cm², ensuring effectiveness in bilirubin breakdown.
| Model | YR02195 |
| Input power | <150VA |
| Light source | Blue tube |
| Light source effective life | 1000 hours |
| Wave length | 400-550nm |
| Irradiance treatment distance | 10~500px |
| Effective area | 1125px×600px |
| Infrared radiation in effective area | ≤10mW/cm² (760nm<λ≤1400nm) |
| Ultraviolet radiation in effective area | ≤1.0×10-5mW/cm² (180nm<λ≤400nm) |
| Operate noise | ≤55dB(A)(ambient noise is lower than 40dB(A)) |
| Basic performance | ≥500μW/cm² |
| Adjust angle | 30°,60°,90° |
| Adjust height | 1100mm~1500mm |
Market Price
The market for infant phototherapy units is competitive, with prices varying based on model specifications and technology. The Infant Bilirubin Phototherapy Unit YR02195 typically falls within a price range of $700 to $1500, making it an affordable yet high-performance option for hospitals and clinics. This pricing aligns the unit within a competitive market bracket, ensuring that healthcare facilities can deliver excellent neonatal care without compromising budgetary constraints.
Frequently Asked Questions
What is the lifespan of the light source in this phototherapy unit?
The light source in the Infant Bilirubin Phototherapy Unit YR02195 has an effective lifespan of 1000 hours, ensuring prolonged use and reducing the need for frequent replacements.
Does the YR02195 model produce significant noise during operation?
No, this model operates at a noise level of ≤55 dB(A), ensuring minimal disruption in a clinical environment.
How is the phototherapy unit adjusted for effective treatment?
The unit allows angle adjustments of 30°, 60°, and 90°, and the height can be modified between 1100 mm to 1500 mm, facilitating optimal positioning and effective treatment outcomes.
Advantages and Disadvantages
The Infant Bilirubin Phototherapy Unit YR02195 offers numerous advantages. Among them is its efficient use of energy at less than 150 VA and its adaptability in clinical settings due to adjustable angles and heights. The broad effective treatment area ensures comprehensive care, while the emission of minimal IR and UV radiation enhances safety for the newborn patients.
However, the need to replace the light source after its 1000-hour lifespan could be seen as a drawback, although this duration is significantly longer compared to some alternative technologies. Institutions must plan regular maintenance checks to ensure uninterrupted performance.
Use of the Product in the Field
The use of the YR02195 phototherapy unit is critical in neonatal care settings where managing bilirubin levels quickly and effectively is essential. It is particularly utilized in treating and managing jaundice in newborns, a common condition that, if left untreated, can lead to serious health issues.
This unit’s adaptability and control options make it a favored choice among healthcare practitioners who require reliability and precision in routine and intensive care environments. The blue light therapy provided by the device aids in the breakdown of bilirubin, converting it to a form that can be excreted by the infant’s body.
Recommendations
For optimal use of the Infant Bilirubin Phototherapy Unit YR02195, follow these recommendations: ensure regular maintenance of the unit, including monitoring the effective life of the light source and replacing it as needed. Position the unit correctly using the adjustable features to ensure consistent exposure to light.
Staff should be trained to operate the unit optimally, understanding the significance of adjusting treatment distances appropriately to maintain effective irradiance levels. Documentation of usage duration and operational conditions can help in managing the lifespan and performance of the equipment efficiently.
If you’re seeking a fusion of innovation and quality, you’ve come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each piece of equipment with a level of excellence. Our intuitive and agile online purchasing channels are designed for your convenience, ensuring the friendliest prices. Don’t hesitate any longer; we bring science to life, and it’s time to be part of our community. https://kalstein.net/en/product/infant-bilirubin-phototherapy-unit-yr02195/.
